Kaposiform Hemangioendothelioma and Therapy With Interferon-α [3]

Medical and Pediatric Oncology

Volumn 41, Issue 6, 2003, Pages 593-

  Deb, Giovanni ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; STEROID; VASCULOTROPIN;

AMPUTATION; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DRUG MEGADOSE; HEMANGIOENDOTHELIOMA; HUMAN; KAPOSIFORM HEMANGIOENDOTHELIOMA; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BIOPSY; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; INTERFERON-ALPHA; PROGNOSIS; SARCOMA, KAPOSI; STEROIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0242407195     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10399     Document Type: Letter

References (2)

1. Walker GM, Abu-Rajab R, MacLennan A, et al. Kasabach-Merritt syndrome in a neonate caused by a kaposiform haemangioendothelioma. Med Pediatr Oncol 2002;38:424-427.
2. Deb G, Donfrancesco A, Ilari I, et al. Hemangioendothelioma: Successful therapy with Interferon-α. A Study in Association With the Italian Pediatric Haematology/Oncology Society (AIEOP). Med Pediatr Oncol 2002;38:118-119.